SlideShare une entreprise Scribd logo
1  sur  22
Compound Screening Using Cancer Stem Cells RuggeroDeMaria Giorgio Stassi Milan Bhagat
Significance of CancerStemCells  Cancer stem cells are responsible for the development,  maintenance and spreading of tumor cells  Tumor relapse results from residual cancer stem cells that survive therapeutic treatment  Cancer stem cells should represent the primary target for new therapeutic strategies aimed at tumor eradication  Cancer stem cell analysis may provide considerable information for prognostic study and patient stratification
Research Options CharacterizationofCancerStemCells Immunohistochemistry Screening: FormalinFixedCancerStemCellArray mRNA and proteinanalysis: Western Blot, RTPCR, Flow Cytometry, Immunoflourescence, ConfocalAnalysis Functionalassays In vitro drug screening  In vivo drugvalidation
Drs. De Maria and Stassihavepioneered cancerstemcellresearch in solid tumors Identification and expansion of human  colon-cancer-intiating cells Lucia Ricci-Vitiani1, Dario G. Lombardi2, Emanuela Pilozzi3, Mauro Biffoni1, Matilde Todaro4, Cesare Peschle1  & Rugerro De Maria1,2 Nature. 2007; 445:111-5.  Established several patient derived CSC lines  Stem cell phenotype maintained over long periods in culture  Technology that allows us to isolate and expand in vitro from   several different tumors Identification and expansion of the tumorigenic lung  cancer stem cell population A Eramo1, F Lotti2, G Sette2, E Pilozzii3, M Biffoni4, A Di Virgilio4, C Conticello2, L Ruco3, Cesare Peschle1  & Rugerro De Maria*,1 Cell Death and Differentation. 2008; 15: 504-514. Colon Cancer Stem Cells Dictate Tumor growth and  Resist Cell Death by Production of Interleukin-4 Matilde Todaro1, Mileidys Perez  Alea1, Anna B. Di Stefano1, Patrizia Cammereri3, Louis Vermeulen5, Flora Iovino1, Claudio Tripodo4,, Antonio Russo2, Gaspare Gulotta3, Jan Paul Medema5,*, and Giorgio Stassi1,* Cell Stem Cell 1, 389-402, October 2007
CancerStemCells (CSC) CSCs are also known as Tumorogenic Cells, Tumor Intiating Cells etc.  Minor subpopulation of tumor cells  Undifferentiated neoplastic cells with some characteristics that represent stem cells  Are able to proliferate indefinitely & produce differentiated progeny  Able to form tumor xenografts when injected into immuno-compromised mice  Based on current reviews, likely responsible for metastatis formation
Asymmetric division Symmetric division Tumorigenic cancerstemcells Non tumorigenic differentiated cell Non tumorigenic transient amplifying progenitors Oldview New view Non Metastatic Potentially Metastatic Potentially metastatic Potentially metastatic Non Metastatic Potentially Metastatic
Human CancerStemCells Leukemia Breast Brain Prostate Colon Lung Liver Melanoma Head and neck Pancreas Ovary Kidney Thyroid Colon Lung Thyroid
Cancerstemcellsare a potential targetforthedevelopment of effectiveanti-cancertherapies Therapieseffective on cancerstemcells CSC Tumordegeneration Therapieseffective on differentiatedcancercells CSC CSC Tumorrelapse Tumorregression
CancerStemCells Cancer stem cells are isolated from solid tumors using specific Culture conditions that allow CSC-containing “tumor spheres” to grow Culture in serum free medium, Containing EGF and FGF2 Sorting Xenograft
CD133 Control Colon cancer stem cell sphere, serial sections
H&E Tumor  database Available Resources  Diagnosis and Tissue Banking TumorDissociation StemCell Culture And Expansion CancerStemCell Banking
CytoinclusionMicroarrays of CancerStemCells As a Tool forCancer Research 	Donor Samples   	Cancer Type 	12		Colon 	12		Lung 	6		Breast 	5		Ovarian 	9		Melanoma 	6		Glioblastoma 	6		Thyroid Colon cancer stem cells
In vitro drug testing  Drug screening is performed by an established high-throughput system that allows monitoring the viability of CSCs using a luminescence-based assay that reliably measures cellular ATP levels.  Incubation StemCell Culture And Expansion Single CellSuspensionDistributed in 96-well Plates  Liquid handling station interconnected to a multimode plate reader  Readout Resistant Sensitive
CSCsdisplaybroadresistance to anti-cancer drugs CSCs derived from 4 colon cancer patients (horizontal strips) were treated with 80 anti-cancer drugs (vertical bars) for 72 and viability was measured by cell titer glo: Anti-Cancer Activity  Results are rainbow coded, with more active compounds in the violetarea (red: 0%, dark violet: 40%)
Inhibition of IL-4 SensitizesColonCancerSpheres to ChemotherapyandTrial-inducedCellDeath Untreated Oxalipl. TRAIL 5-FU Ox+5-FU IgG anti-IL-4
In Vivo Drug Testing Cancer Stem Cells are able to generate Xenografts that Histologically and Phenotypically Reproduce the Patient Tumor Colon Cancer NSCLC PatientTumor CSC Xenograft PatientTumor CSC Xenograft H&E H&E CDX2 HMW-CK
EGFP CMV PGK LUCIFERASE LTR LTR presorting postsorting GFP+ Imaging of CSC-based tumors The CSC samples are genetically labelled with markers that allowed the  non-invasive monitoring of tumor growth and response to treatment 108 106 Luciferaseactivity 104 102 100 Control Tw-GFP-Luc
Colon Cancer Stem Cell-based Models Orthotopic Lung metastasis Liver metastasis Haematoxylin & Eosin staining of an orthotopic tumor, lung and liver metastasis generated from colon cancer stem cells
Breast Cancer Stem Cells Grow As Spheres Expressing ALDH InfiltratingDuctalBreastCancer CK14 PrimaryCancerCells Serum-freecultures with EGF + FGF CK14 ALDH 2 days 7days Breast cancer spheres CK14 Differentiation in presence of FBS
Colon Cancer Stem Cell-based Models 100 PBS 80 IL-4 DM 60 cell viability (%) 40 20 0 Untreated Doxo w/o Doxo IL4DM +Doxo IL4DM  Orange acridine/ethidium bromide staining of breast cancer spheres treated with Doxorubicin and IL-4 DM (IL-4 blocker)
Colon Cancer Stem Cell-based Models Blocking IL-4 in combination with chemotherapy prevents tumor growth generated by breast CSC Doxo IL-4DM +Doxo Control IL-4DM 2.5 PBS 2 Tunel 1.5 Doxo tumor size (cm3) 1 IL-4 DM  0.5 IL-4 DM+Doxo Azan Mallory 0 0 7 14 21 28 35 days
Thanks! Tristar Technology Group 9700 Great Seneca Highway Rockville, MD 20850 U.S.A www.tristargroup.us Rockville, MD Headquarters Hamburg, Germany Main Repository Array Manufacturing Contract Research Catania, Italy Tissue Repository

Contenu connexe

Tendances

Cancer Stem Cells
Cancer Stem CellsCancer Stem Cells
Cancer Stem CellsDinaSalloom
 
Basics of immunotherapy in colorectal cancer
Basics of immunotherapy in colorectal cancerBasics of immunotherapy in colorectal cancer
Basics of immunotherapy in colorectal cancerMohamed Abdulla
 
16. identification and characterization of cancer stem cells in liver cancer ...
16. identification and characterization of cancer stem cells in liver cancer ...16. identification and characterization of cancer stem cells in liver cancer ...
16. identification and characterization of cancer stem cells in liver cancer ...Dr. Wilfred Lin (Ph.D.)
 
Identification Of Pancreatic Cancer Stem Cells
Identification Of Pancreatic Cancer Stem CellsIdentification Of Pancreatic Cancer Stem Cells
Identification Of Pancreatic Cancer Stem Cellsbegelfer
 
Stem cells as a cause of cancers
Stem cells as a cause of cancersStem cells as a cause of cancers
Stem cells as a cause of cancersAndleeb Sultana
 
EmergingUnderstandingofMultiscaleTumorHeterogeneityDecember2014
EmergingUnderstandingofMultiscaleTumorHeterogeneityDecember2014EmergingUnderstandingofMultiscaleTumorHeterogeneityDecember2014
EmergingUnderstandingofMultiscaleTumorHeterogeneityDecember2014Rafael Casiano
 
CANCER STEM CELLS
CANCER STEM CELLSCANCER STEM CELLS
CANCER STEM CELLSsathish sak
 
KANDAKUMAR S (KK) Molecular Oncology Lab (MOL) seminar
KANDAKUMAR S (KK) Molecular Oncology Lab (MOL) seminarKANDAKUMAR S (KK) Molecular Oncology Lab (MOL) seminar
KANDAKUMAR S (KK) Molecular Oncology Lab (MOL) seminarS KANDAKUMAR CUDDALORE
 
Comparison of risk factors and molecular analysis of right-sided colon and le...
Comparison of risk factors and molecular analysis of right-sided colon and le...Comparison of risk factors and molecular analysis of right-sided colon and le...
Comparison of risk factors and molecular analysis of right-sided colon and le...M. Luisetto Pharm.D.Spec. Pharmacology
 
Hall marks of Cancer
Hall marks of CancerHall marks of Cancer
Hall marks of Cancerneralagundi
 
Alain Toledano : Test and genomic profile : what future in breast cancer trea...
Alain Toledano : Test and genomic profile : what future in breast cancer trea...Alain Toledano : Test and genomic profile : what future in breast cancer trea...
Alain Toledano : Test and genomic profile : what future in breast cancer trea...breastcancerupdatecongress
 
Biology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerBiology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerRHMBONCO
 
Cancer and metastasis
Cancer and metastasisCancer and metastasis
Cancer and metastasisSandeep Kumar
 
Garcia-Pravia et al. - PlosOne 2013
Garcia-Pravia et al. - PlosOne 2013Garcia-Pravia et al. - PlosOne 2013
Garcia-Pravia et al. - PlosOne 2013Jose A. Galvan
 
Tumor stem cell reprogramming as a driver of cancer as
Tumor stem cell reprogramming as a driver of cancer asTumor stem cell reprogramming as a driver of cancer as
Tumor stem cell reprogramming as a driver of cancer asmds-web
 
Basic steps in cancer research by Prof. Mohamed Labib Salem, PhD
Basic steps in cancer research by Prof. Mohamed Labib Salem, PhDBasic steps in cancer research by Prof. Mohamed Labib Salem, PhD
Basic steps in cancer research by Prof. Mohamed Labib Salem, PhDProf. Mohamed Labib Salem
 
Swjcst comparison of risk factors and molecular analysis of right sided colon...
Swjcst comparison of risk factors and molecular analysis of right sided colon...Swjcst comparison of risk factors and molecular analysis of right sided colon...
Swjcst comparison of risk factors and molecular analysis of right sided colon...M. Luisetto Pharm.D.Spec. Pharmacology
 

Tendances (20)

Cancer Stem Cells
Cancer Stem CellsCancer Stem Cells
Cancer Stem Cells
 
Basics of immunotherapy in colorectal cancer
Basics of immunotherapy in colorectal cancerBasics of immunotherapy in colorectal cancer
Basics of immunotherapy in colorectal cancer
 
16. identification and characterization of cancer stem cells in liver cancer ...
16. identification and characterization of cancer stem cells in liver cancer ...16. identification and characterization of cancer stem cells in liver cancer ...
16. identification and characterization of cancer stem cells in liver cancer ...
 
Identification Of Pancreatic Cancer Stem Cells
Identification Of Pancreatic Cancer Stem CellsIdentification Of Pancreatic Cancer Stem Cells
Identification Of Pancreatic Cancer Stem Cells
 
Stem cells as a cause of cancers
Stem cells as a cause of cancersStem cells as a cause of cancers
Stem cells as a cause of cancers
 
Drugs Used in Neoplastic Disorders
Drugs Used in Neoplastic DisordersDrugs Used in Neoplastic Disorders
Drugs Used in Neoplastic Disorders
 
EmergingUnderstandingofMultiscaleTumorHeterogeneityDecember2014
EmergingUnderstandingofMultiscaleTumorHeterogeneityDecember2014EmergingUnderstandingofMultiscaleTumorHeterogeneityDecember2014
EmergingUnderstandingofMultiscaleTumorHeterogeneityDecember2014
 
CANCER STEM CELLS
CANCER STEM CELLSCANCER STEM CELLS
CANCER STEM CELLS
 
KANDAKUMAR S (KK) Molecular Oncology Lab (MOL) seminar
KANDAKUMAR S (KK) Molecular Oncology Lab (MOL) seminarKANDAKUMAR S (KK) Molecular Oncology Lab (MOL) seminar
KANDAKUMAR S (KK) Molecular Oncology Lab (MOL) seminar
 
Comparison of risk factors and molecular analysis of right-sided colon and le...
Comparison of risk factors and molecular analysis of right-sided colon and le...Comparison of risk factors and molecular analysis of right-sided colon and le...
Comparison of risk factors and molecular analysis of right-sided colon and le...
 
Hall marks of Cancer
Hall marks of CancerHall marks of Cancer
Hall marks of Cancer
 
Alain Toledano : Test and genomic profile : what future in breast cancer trea...
Alain Toledano : Test and genomic profile : what future in breast cancer trea...Alain Toledano : Test and genomic profile : what future in breast cancer trea...
Alain Toledano : Test and genomic profile : what future in breast cancer trea...
 
Biology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerBiology And Pathophysiology Of Cancer
Biology And Pathophysiology Of Cancer
 
Cancer and metastasis
Cancer and metastasisCancer and metastasis
Cancer and metastasis
 
Garcia-Pravia et al. - PlosOne 2013
Garcia-Pravia et al. - PlosOne 2013Garcia-Pravia et al. - PlosOne 2013
Garcia-Pravia et al. - PlosOne 2013
 
Carcinoma of unknown primary
Carcinoma of unknown primaryCarcinoma of unknown primary
Carcinoma of unknown primary
 
Tumor stem cell reprogramming as a driver of cancer as
Tumor stem cell reprogramming as a driver of cancer asTumor stem cell reprogramming as a driver of cancer as
Tumor stem cell reprogramming as a driver of cancer as
 
Basic steps in cancer research by Prof. Mohamed Labib Salem, PhD
Basic steps in cancer research by Prof. Mohamed Labib Salem, PhDBasic steps in cancer research by Prof. Mohamed Labib Salem, PhD
Basic steps in cancer research by Prof. Mohamed Labib Salem, PhD
 
Swjcst comparison of risk factors and molecular analysis of right sided colon...
Swjcst comparison of risk factors and molecular analysis of right sided colon...Swjcst comparison of risk factors and molecular analysis of right sided colon...
Swjcst comparison of risk factors and molecular analysis of right sided colon...
 
Cancer
CancerCancer
Cancer
 

Similaire à TriStar CSC

ANNOTATION ON THE BASIC CONCEPT OF NEOPLASM..PPTX
ANNOTATION ON THE BASIC CONCEPT OF NEOPLASM..PPTXANNOTATION ON THE BASIC CONCEPT OF NEOPLASM..PPTX
ANNOTATION ON THE BASIC CONCEPT OF NEOPLASM..PPTXMuhammadShahriarHoss1
 
Using biomarkers to monitor the dynamics of tumor
Using biomarkers to monitor the dynamics of tumorUsing biomarkers to monitor the dynamics of tumor
Using biomarkers to monitor the dynamics of tumorsummer elmorshidy
 
3Mar15-Ramhold Departmental Seminar (edited)
3Mar15-Ramhold Departmental Seminar (edited)3Mar15-Ramhold Departmental Seminar (edited)
3Mar15-Ramhold Departmental Seminar (edited)Christopher Ramhold
 
Cancer and tumor markers
Cancer and tumor markersCancer and tumor markers
Cancer and tumor markersKshema Thakur
 
Stem Cells in Cancer: A Review
Stem Cells in Cancer:  A ReviewStem Cells in Cancer:  A Review
Stem Cells in Cancer: A ReviewJovana Grbic
 
Advancements in Cancer Research with Special Reference to Pathogenesis and Di...
Advancements in Cancer Research with Special Reference to Pathogenesis and Di...Advancements in Cancer Research with Special Reference to Pathogenesis and Di...
Advancements in Cancer Research with Special Reference to Pathogenesis and Di...Rahul Kadam
 
SCT60103 Group 2 Presentation
SCT60103 Group 2 PresentationSCT60103 Group 2 Presentation
SCT60103 Group 2 PresentationJayden On
 
بدر الشهاري.ppt
بدر الشهاري.pptبدر الشهاري.ppt
بدر الشهاري.pptosama727046
 
Cellular level cancer therapy
Cellular level  cancer therapyCellular level  cancer therapy
Cellular level cancer therapySuganyaPaulraj
 
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...ijtsrd
 
1. cancer care.pdf medical surgical nursing 1
1. cancer care.pdf medical surgical nursing 11. cancer care.pdf medical surgical nursing 1
1. cancer care.pdf medical surgical nursing 1akoeljames8543
 

Similaire à TriStar CSC (20)

ANNOTATION ON THE BASIC CONCEPT OF NEOPLASM..PPTX
ANNOTATION ON THE BASIC CONCEPT OF NEOPLASM..PPTXANNOTATION ON THE BASIC CONCEPT OF NEOPLASM..PPTX
ANNOTATION ON THE BASIC CONCEPT OF NEOPLASM..PPTX
 
Using biomarkers to monitor the dynamics of tumor
Using biomarkers to monitor the dynamics of tumorUsing biomarkers to monitor the dynamics of tumor
Using biomarkers to monitor the dynamics of tumor
 
3Mar15-Ramhold Departmental Seminar (edited)
3Mar15-Ramhold Departmental Seminar (edited)3Mar15-Ramhold Departmental Seminar (edited)
3Mar15-Ramhold Departmental Seminar (edited)
 
Cancer and tumor markers
Cancer and tumor markersCancer and tumor markers
Cancer and tumor markers
 
Stem Cells in Cancer: A Review
Stem Cells in Cancer:  A ReviewStem Cells in Cancer:  A Review
Stem Cells in Cancer: A Review
 
Advancements in Cancer Research with Special Reference to Pathogenesis and Di...
Advancements in Cancer Research with Special Reference to Pathogenesis and Di...Advancements in Cancer Research with Special Reference to Pathogenesis and Di...
Advancements in Cancer Research with Special Reference to Pathogenesis and Di...
 
Tumour markers
Tumour markersTumour markers
Tumour markers
 
Lynch syndrome
Lynch syndromeLynch syndrome
Lynch syndrome
 
SCT60103 Group 2 Presentation
SCT60103 Group 2 PresentationSCT60103 Group 2 Presentation
SCT60103 Group 2 Presentation
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
Anticancer.ppt
Anticancer.pptAnticancer.ppt
Anticancer.ppt
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
بدر الشهاري.ppt
بدر الشهاري.pptبدر الشهاري.ppt
بدر الشهاري.ppt
 
Cellular level cancer therapy
Cellular level  cancer therapyCellular level  cancer therapy
Cellular level cancer therapy
 
Staging an tumor markers
Staging an tumor markersStaging an tumor markers
Staging an tumor markers
 
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...
 
Genome wide study
Genome wide studyGenome wide study
Genome wide study
 
1. cancer care.pdf medical surgical nursing 1
1. cancer care.pdf medical surgical nursing 11. cancer care.pdf medical surgical nursing 1
1. cancer care.pdf medical surgical nursing 1
 

Dernier

Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...apidays
 
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Angeliki Cooney
 
Cyberprint. Dark Pink Apt Group [EN].pdf
Cyberprint. Dark Pink Apt Group [EN].pdfCyberprint. Dark Pink Apt Group [EN].pdf
Cyberprint. Dark Pink Apt Group [EN].pdfOverkill Security
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...Martijn de Jong
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProduct Anonymous
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfsudhanshuwaghmare1
 
[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdfSandro Moreira
 
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKSpring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKJago de Vreede
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FMESafe Software
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodJuan lago vázquez
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MIND CTI
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Victor Rentea
 
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistandanishmna97
 
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...apidays
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...Zilliz
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processorsdebabhi2
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century educationjfdjdjcjdnsjd
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDropbox
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024The Digital Insurer
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...apidays
 

Dernier (20)

Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
 
Cyberprint. Dark Pink Apt Group [EN].pdf
Cyberprint. Dark Pink Apt Group [EN].pdfCyberprint. Dark Pink Apt Group [EN].pdf
Cyberprint. Dark Pink Apt Group [EN].pdf
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf
 
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKSpring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
 
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistan
 
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 

TriStar CSC

  • 1. Compound Screening Using Cancer Stem Cells RuggeroDeMaria Giorgio Stassi Milan Bhagat
  • 2. Significance of CancerStemCells Cancer stem cells are responsible for the development, maintenance and spreading of tumor cells Tumor relapse results from residual cancer stem cells that survive therapeutic treatment Cancer stem cells should represent the primary target for new therapeutic strategies aimed at tumor eradication Cancer stem cell analysis may provide considerable information for prognostic study and patient stratification
  • 3. Research Options CharacterizationofCancerStemCells Immunohistochemistry Screening: FormalinFixedCancerStemCellArray mRNA and proteinanalysis: Western Blot, RTPCR, Flow Cytometry, Immunoflourescence, ConfocalAnalysis Functionalassays In vitro drug screening In vivo drugvalidation
  • 4. Drs. De Maria and Stassihavepioneered cancerstemcellresearch in solid tumors Identification and expansion of human colon-cancer-intiating cells Lucia Ricci-Vitiani1, Dario G. Lombardi2, Emanuela Pilozzi3, Mauro Biffoni1, Matilde Todaro4, Cesare Peschle1 & Rugerro De Maria1,2 Nature. 2007; 445:111-5. Established several patient derived CSC lines Stem cell phenotype maintained over long periods in culture Technology that allows us to isolate and expand in vitro from several different tumors Identification and expansion of the tumorigenic lung cancer stem cell population A Eramo1, F Lotti2, G Sette2, E Pilozzii3, M Biffoni4, A Di Virgilio4, C Conticello2, L Ruco3, Cesare Peschle1 & Rugerro De Maria*,1 Cell Death and Differentation. 2008; 15: 504-514. Colon Cancer Stem Cells Dictate Tumor growth and Resist Cell Death by Production of Interleukin-4 Matilde Todaro1, Mileidys Perez Alea1, Anna B. Di Stefano1, Patrizia Cammereri3, Louis Vermeulen5, Flora Iovino1, Claudio Tripodo4,, Antonio Russo2, Gaspare Gulotta3, Jan Paul Medema5,*, and Giorgio Stassi1,* Cell Stem Cell 1, 389-402, October 2007
  • 5. CancerStemCells (CSC) CSCs are also known as Tumorogenic Cells, Tumor Intiating Cells etc. Minor subpopulation of tumor cells Undifferentiated neoplastic cells with some characteristics that represent stem cells Are able to proliferate indefinitely & produce differentiated progeny Able to form tumor xenografts when injected into immuno-compromised mice Based on current reviews, likely responsible for metastatis formation
  • 6. Asymmetric division Symmetric division Tumorigenic cancerstemcells Non tumorigenic differentiated cell Non tumorigenic transient amplifying progenitors Oldview New view Non Metastatic Potentially Metastatic Potentially metastatic Potentially metastatic Non Metastatic Potentially Metastatic
  • 7. Human CancerStemCells Leukemia Breast Brain Prostate Colon Lung Liver Melanoma Head and neck Pancreas Ovary Kidney Thyroid Colon Lung Thyroid
  • 8. Cancerstemcellsare a potential targetforthedevelopment of effectiveanti-cancertherapies Therapieseffective on cancerstemcells CSC Tumordegeneration Therapieseffective on differentiatedcancercells CSC CSC Tumorrelapse Tumorregression
  • 9. CancerStemCells Cancer stem cells are isolated from solid tumors using specific Culture conditions that allow CSC-containing “tumor spheres” to grow Culture in serum free medium, Containing EGF and FGF2 Sorting Xenograft
  • 10. CD133 Control Colon cancer stem cell sphere, serial sections
  • 11. H&E Tumor database Available Resources Diagnosis and Tissue Banking TumorDissociation StemCell Culture And Expansion CancerStemCell Banking
  • 12. CytoinclusionMicroarrays of CancerStemCells As a Tool forCancer Research Donor Samples Cancer Type 12 Colon 12 Lung 6 Breast 5 Ovarian 9 Melanoma 6 Glioblastoma 6 Thyroid Colon cancer stem cells
  • 13. In vitro drug testing Drug screening is performed by an established high-throughput system that allows monitoring the viability of CSCs using a luminescence-based assay that reliably measures cellular ATP levels. Incubation StemCell Culture And Expansion Single CellSuspensionDistributed in 96-well Plates Liquid handling station interconnected to a multimode plate reader Readout Resistant Sensitive
  • 14. CSCsdisplaybroadresistance to anti-cancer drugs CSCs derived from 4 colon cancer patients (horizontal strips) were treated with 80 anti-cancer drugs (vertical bars) for 72 and viability was measured by cell titer glo: Anti-Cancer Activity Results are rainbow coded, with more active compounds in the violetarea (red: 0%, dark violet: 40%)
  • 15. Inhibition of IL-4 SensitizesColonCancerSpheres to ChemotherapyandTrial-inducedCellDeath Untreated Oxalipl. TRAIL 5-FU Ox+5-FU IgG anti-IL-4
  • 16. In Vivo Drug Testing Cancer Stem Cells are able to generate Xenografts that Histologically and Phenotypically Reproduce the Patient Tumor Colon Cancer NSCLC PatientTumor CSC Xenograft PatientTumor CSC Xenograft H&E H&E CDX2 HMW-CK
  • 17. EGFP CMV PGK LUCIFERASE LTR LTR presorting postsorting GFP+ Imaging of CSC-based tumors The CSC samples are genetically labelled with markers that allowed the non-invasive monitoring of tumor growth and response to treatment 108 106 Luciferaseactivity 104 102 100 Control Tw-GFP-Luc
  • 18. Colon Cancer Stem Cell-based Models Orthotopic Lung metastasis Liver metastasis Haematoxylin & Eosin staining of an orthotopic tumor, lung and liver metastasis generated from colon cancer stem cells
  • 19. Breast Cancer Stem Cells Grow As Spheres Expressing ALDH InfiltratingDuctalBreastCancer CK14 PrimaryCancerCells Serum-freecultures with EGF + FGF CK14 ALDH 2 days 7days Breast cancer spheres CK14 Differentiation in presence of FBS
  • 20. Colon Cancer Stem Cell-based Models 100 PBS 80 IL-4 DM 60 cell viability (%) 40 20 0 Untreated Doxo w/o Doxo IL4DM +Doxo IL4DM Orange acridine/ethidium bromide staining of breast cancer spheres treated with Doxorubicin and IL-4 DM (IL-4 blocker)
  • 21. Colon Cancer Stem Cell-based Models Blocking IL-4 in combination with chemotherapy prevents tumor growth generated by breast CSC Doxo IL-4DM +Doxo Control IL-4DM 2.5 PBS 2 Tunel 1.5 Doxo tumor size (cm3) 1 IL-4 DM 0.5 IL-4 DM+Doxo Azan Mallory 0 0 7 14 21 28 35 days
  • 22. Thanks! Tristar Technology Group 9700 Great Seneca Highway Rockville, MD 20850 U.S.A www.tristargroup.us Rockville, MD Headquarters Hamburg, Germany Main Repository Array Manufacturing Contract Research Catania, Italy Tissue Repository